Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Teva's innovative portfolio continues to drive strong performance and future potential. The company has announced its target ...

Lennar transferring its land banking assets into Millrose. Millrose will now be responsible for acquiring, developing, and ...

Gladstone Capital showcased operational resilience and a strong funding pipeline in Q2 2025, with management emphasizing portfolio recovery and growth amid market dynamics. While net originations ...

the ability to shift underlying portfolio investments to take advantage of shorter-term opportunities is invaluable. This approach also allows for more personalized adjustments concerning tax ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Management maintained a confident and measured tone, highlighting the stability of the portfolio and disciplined decision-making. CEO Halfacre emphasized long-term value creation and patient ...

Bristol-Myers Squibb’s management discussed product-specific performance, pipeline progress ... s ability to offset headwinds in its legacy portfolio and capitalize on recent product launches.

Discover the top 7 undervalued Oil, Gas & Consumable Fuels stocks for Thursday, May 29 based on AAII’s Stock Grades.

Park Hotels & Resorts has completed the sale of the Hyatt Centric Fisherman's Wharf in San Francisco, California, US, for ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results , but sales fell by 5.6% year on year to ...

Management shared that the pipeline of expected fundings is robust, with several deals in advanced stages, indicating plans to grow the portfolio. Marcotte projected that recent market volatility ...